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Introduction: We report on a very rare case of a supratentorial primitive neuroectodermal tumor in an adult, which
presented with intracerebral hemorrhage, and review the relevant medical literature.
Case presentation: A 42-year-old Caucasian man complained of a sudden headache and nausea-vomiting. The
patient rapidly deteriorated to coma. An emergency computed tomography scan showed an extensive
intraparenchymal hemorrhage that caused significant mass effect and tonsilar herniation. During surgery, an
increased intracranial pressure was recorded and extensive bilateral decompressive craniectomies were performed.
A cherry-like intraparenchymal lesion was found in his right frontal lobe and resected. The patient died in the
intensive care unit after approximately 48 hours. The resected lesion was identified as a central nervous system
primitive neuroectodermal tumor.
Conclusion: Supratentorial primitive neuroectodermal tumors must be considered in the differential diagnosis of
space-occupying lesions in adults. Spontaneous supratentorial hemorrhage due to primitive neuroectodermal
tumors is an extremely rare but potentially lethal event.Introduction
Primitive neuroectodermal tumors (PNET) constitute a
heterogeneous group of embryonal malignancies that are
composed of undifferentiated or poorly differentiated
cells and are characterized by an aggressive clinical be-
havior [1,2]. They usually occur in children and adoles-
cents and may arise in the cerebral hemispheres, the
brainstem or the spinal cord [1,3]. Although they are
common primary central nervous system tumors in chil-
dren, PNETs are extremely rare in adults, representing
less than 0.5% of all intracranial tumors [4]. The defin-
ition of PNETs in the 2007 World Health Organization
(WHO) classification of tumors affecting the central
nervous system is made regardless of their supra- or
infratentorial location [2].* Correspondence: kpaterakis@yahoo.com
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distribution, and reproduction in any mediumPNETs in adults usually present with signs of in-
creased intracranial pressure (ICP), seizures and/or focal
neurological deficits [4-15]. However, to the best of our
knowledge, there is no report on a supratentorial PNET
presenting with a massive and fatal intracerebral
hemorrhage. In this case report, we present the case of a
patient with a supratentorial PNET, presenting with
massive intracerebral hemorrhage. With this opportun-
ity, we also review the pertinent literature.
Case presentation
A 42-year-old Caucasian man was admitted to the emer-
gency department of a district hospital in a comatose
condition (Glasgow Coma Scale Score 4 out of 15). His
relatives reported that he initially complained of a
sudden onset of headache and had several episodes of
emesis. He was sedated, intubated and urgently
transported to our teaching hospital. On arrival at our
facility, he was unresponsive to verbal and painful stim-
uli, and his pupils were bilaterally dilated and non-Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Computed tomography scan images. (a) Preoperative brain computed tomography scan showing an extensive intraparenchymal
hemorrhagic lesion in the right frontal lobe (white arrows), with severe diffuse perilesional edema affecting the whole ipsilateral hemisphere, and
compressing the ipsilateral lateral ventricle and causing significant mass effect. (b) Immediate postoperative computed tomography scan showing
the low-density appearance of both the cerebral hemispheres, suggesting severe brain ischemia (black arrows).
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his brain showed an extensive intraparenchymal
hemorrhagic lesion, causing significant mass effect and
tonsilar herniation (Figure 1a).
An external ventricular drain was inserted into his left
lateral ventricle, and an intraparenchymal ICP fiber optic
monitor was inserted into the right frontal perilesional
area. His ICP was elevated (>40mmHg), and extensive
bilateral decompressive craniectomies were urgently
performed. During the surgery, and after the evacuation
of the hematoma, a cherry-like intraparenchymal lesion
was found in his edematous right frontal lobe, whichFigure 2 Intraoperative photograph. A cherry-like round
lobulated lesion was demonstrated in the right frontal lobe
(white arrows).was resected (Figure 2). Decompressive duraplasties
were performed bilaterally and after surgery he was
transferred to the intensive care unit for observation and
further management.
A head CT scan at the end of surgery showed diffuse
areas of low-density in both brain hemispheres,
suggesting severe ischemia (Figure 1b). His condition
continued to deteriorate, with ICP rising to 65mmHg
despite the performed decompressive craniectomies and
the aggressive medical management of his intracranial
hypertension. He subsequently developed multi-organ
failure, and died approximately 48 hours after his
admission.
The surgical specimen was sent for microscopic and
immunohistochemical pathological analysis. Permanent
specimen sections were stained with hematoxylin and
eosin and were assessed via immunohistochemistry for
vimentin, synaptophysin, glial-fibrillary acidic protein
and Ki-67 to measure the proliferation index. Uniform
neoplastic medium-sized cells, with round to oval
hyperchromatic nuclei, were present and positive for
vimentin, synaptophysin and cluster of differentiation
56, but were negative for glial-fibrillary acidic protein
(Figure 3). The Ki-67 index was approximately 40%, in-
dicating increased mitotic activity and a high-grade ma-
lignancy. The resected lesion was identified as a central
nervous system PNET.
Discussion
The term PNET was introduced in 1973 for describing
initially supratentorial, pediatric brain tumors that were
largely undifferentiated or primitive but contained small
foci of glial or neuroblastic differentiated cells of primitive
neuroectodermal origin [1]. PNETs of the central nervous
system include neuroblastomas, ganglioneuroblastomas,
Figure 3 The histological findings were compatible with primitive neuroectodermal tumor. (a) Photomicrograph (original magnification,
×100; hematoxylin-eosin stain) demonstrating small tumor cells with round to oval hyperchromatic nuclei and scant cytoplasm with distinct
outline (white arrows). (b) Photomicrograph (original magnification, ×400; immunohistochemical stain) showing intense positivity for
synaptophysin (black arrows).
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mors with abundant neuropil and true rosettes, and not
otherwise specified PNET tumors [2]. The previous long-
standing controversy regarding the inclusion of medullo-
blastomas and pineoblastomas into the PNET category
has been resolved by the WHO tumor classification [2].
We performed a literature review in MEDLINE and
PubMed, limited to the English language and ranging
from January 1973 to December 2012. We used as key
terms the words ‘PNET’ or ‘primitive neuroectodermal
tumour’, intracerebral hemorrhage’ or ‘intracerebral
haemorrhage’ or ‘intracerebral bleeding’ and ‘adults’,
‘man’, ‘woman’. No patients younger than 20 years old
were included in the literature review. Altogether, 278
articles were retrieved. Two of the authors (EKP and
AGB) read the abstracts of the gathered articles and all
irrelevant articles were eliminated. The full-text articles
of the remaining hits were gathered and thoroughly
studied and their references scrutinized for further rele-
vant cases. The results are presented in Table 1.
Twenty six publications have reported on 70 supratentorial
not otherwise specified PNET cases in adults. These tu-
mors occurred in adults up to 88 years old [11] with a
small overall male predominance (male to female ratio,
four to three) (Table 1).
Most patients present with symptoms and signs of
raised ICP such as headaches, nausea and/or vomiting,
confusion and papilledema because of the rapid tumor
growth [4,6-8,13,15], as in our case. Furthermore, an adult
supratentorial PNET may present with focal neurological
signs and deficits, such as limb paresis, aphasia, facial
palsy and visual field defects, depending on the anatomic
location of the tumor [7,10,11,14,18,22,23,26]. Occasion-
ally, the clinical presentation may involve seizures [5,9,12].
To the best of our knowledge, this is the first report of a
patient with a supratentorial PNET presenting in a coma-
tose condition due to massive intracranial hemorrhage.
Adult PNETs demonstrate no specific imaging charac-
teristics in comparison to their counterparts in children.They may appear as isodense or hyperdense lesions on a CT
scan, with intratumoral calcifications or microhemorrhages
[4]. On magnetic resonance imaging, they usually appear as
multilobulated, well-demarcated masses, showing heteroge-
neous signal intensity on T1 and T2 weighted images. They
may have cystic, necrotic or hemorrhagic components, while
their solid parts usually appear hypointense on T1-weighted
and hyperintense on T2-weighted images, and they enhance
after intravenous administration of a paramagnetic contrast.
Moderate to severe surrounding edema is usually present in
adult supratentorial PNETs [4]. Proton magnetic resonance
spectroscopic studies have shown nonspecific increased cho-
line and lactate, and decreased N-acetyl-aspartate concen-
trations. The differential preoperative diagnosis of suspected
supratentorial PNET should include glioblastoma, anaplastic
oligodendroglioma and metastatic tumor. It has to be em-
phasized that the possibility of mislabeling a diffuse highly
malignant glioma with foci resembling PNET is extremely
high [3].
On macroscopic examination, adult PNETs usually
appear as lobulated, purple-grayish or pinkish masses.
On histology, the tumor cell population consists of un-
differentiated small cells with ill-defined, scanty cyto-
plasm, and round or oval cells with hyperchromatic
nuclei [2,3]. Mitotic activity is variable. Microscopic cal-
cifications, necroses and Homer-Wright rosettes are also
observed in a number of cases. The vascularity of the tu-
mors varies, whereas endothelial cell proliferation within
the vessel wall is regularly observed [2,3,15].
Newer genetic analysis studies have demonstrated that
PNETs are characterized by MYCN or MYCC gene am-
plifications, and polysomies of chromosomes 2 and 8
[3]. Various genetic features seem to be associated with
prognosis and clinical outcome. The presence of MYCN
or MYCC gene amplifications has been shown to be as-
sociated with decreased survival. Similarly, polysomies of
chromosomes 2 and 8 have been individually associated
with decreased survival in children, and the combined
presence appears to be an even more unfavorable
Table 1 Summary table of case reports on adult patients with supratentorial primitive neuroectodermal tumor
Study Number of
patients
Age (years) Sex Clinical presentation Intracerebral
hemorrhage
Treatment Outcome
Bellis et al. [5] 1 57 M Seizures No S, R Died after five months
Gaffney et al. [6] 7 22 to 35 2F+5M Increased ICP No S, ±R, ±C Seven months to
nine years
Kuratsu et al. [7] 1 31 M Headache, hemiparesis,
papilledema
No S, C Died after 15 months
Louis et al. [16] 1 40 M Hydrocephalus No S, R Spinal metastasis after
18 years
Miyazawa et al. [17] 1 21 F Headache No S, R, C 27 years follow-up
Selassie et al. [18] 1 60 M Visual difficulty No S, R, C Died after eight months
Pickuth and Leutloff [8] 5 20 to 57 2F+3M Increased ICP No S, ±R, ±C Died after four to
25 months
Sanno et al. [9] 1 50 F Seizures No S NS
Takeuchi et al. [19] 1 69 M Decline of higher
cortical functions
No S, R, C 30 months follow-up
Gyure et al. [20] 4 30 to 40 4M Various No S, ±R, ±C Died after two to
five years
Prados et al. [21] 4 21 to 42 3M+1F Not specified No S, R, C 23 to 66 months
Gnanaligham et al. [22] 1 38 F Vertigo - diplopia No S Died after five months
Krishnamurthy et al. [23] 1 51 F Visual field defects No S, R, C Alive at 18 months
follow-up
Balafouta et al. [10] 1 60 M Headache, Broca’s aphasia
and hemiparesis
No S, R, C 12 months
Majós et al. [24] 7 21 to 67 NS NS No NS NS
Kim et al. [4] 12 20 to 64 6M+6F Increased ICP No S, ±R, ±C Mean survival 86
months
Kouyialis et al. [25] 1 32 F Headaches, fatigue,
gait disturbances
No S Alive at 24 months
Shingu et al. [11] 1 88 F Disturbance of consciousness,
left hemiplegia
No Biopsy, C Died after six months
Krampulz et al. [12] 1 33 M Seizures, dizziness No S, R, C Alive after 17 years
Han et al. [13] 1 29 M Increased ICP No S, R, C Died after two years
from spine and lung
metastases
Terheggen et al. [26] 1 26 M Headache, nausea,
coordination problems and
monoparesis
No S, R Multiple liver metastases
and local tumor
recurrence
Alive after four years
Ohba et al. [14] 1 56 M Facial palsy No S, R Died after five months
Prayson [27] 1 48 F Headaches and confusion No S Recurrence after 10
months
Died after 13 months
Gessi et al. [28] 12 32 to 64 6F+6M NS No NS Varied from death at
two months to five
years disease free
Lawandy et al. [15] 1 22 M Increased ICP No S NS




+/−: on some cases; C chemotherapy, F female, ICP intracranial pressure, M male, NS not specified, R radiotherapy; S surgery.
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characteristics are based on pediatric cases because adult
cases are extremely rare. Therefore, extrapolation of the
prognostic role of such genetic features in PNET cases
in adults may be inaccurate.
Extensive surgical resection of adult PNET is the usu-
ally recommended mode of treatment, followed by
radiotherapy and chemotherapy (Table 1). Postsurgical
irradiation of the whole craniospinal axis may be
employed, even when there is no evidence of spinal
seeding [4]. The employed mean dose is 54Gy for the
brain and 31Gy for the spinal cord [4]. The exact role of
stereotactic radiosurgery employment, especially in cases
of partially resected PNET tumors, remains to be
defined [2,4].
The prognosis for adults with supratentorial PNETs
seems to be worse than that of their pediatric counter-
parts [3-5,7,29]. The reported overall survival of PNETs
in the pediatric population ranges between 29% and 57%
[3], whereas Kim et al. [4] reported three-year mean sur-
vival of 75% in their series of adult patients. Most adults,
with limited exceptions, with a supratentorial PNET die
within a year of the initial diagnosis (Table 1). There are
a few reports on local recurrence and spinal and lung
metastases [13,16,26,27]. For pediatric patients with
supratentorial PNETs, the prognosis correlates with age,
extent of necrosis and tumor dissemination [4]. By con-
trast, in adults the most important prognostic factor is
considered to be the Ki-67 index. Kim et al. [4] reported
that adult patients with a Ki-67 index greater than 30%
demonstrated very poor outcome, with a mean postoper-
ative survival time of eight months. Similarly, in our
patient, his labeling index Ki-67 was approximately 40%.
Conclusions
Supratentorial PNETs must be considered in the differ-
ential diagnosis of space-occupying lesions in adults.
Spontaneous supratentorial hemorrhage is an extremely
rare but potentially lethal presentation of PNET in
adults.
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